Recordati Updates Market on Progress of Share Buyback Programme

Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an update.

Recordati has provided an update on its ongoing share buyback programme, launched in December 2025 to support existing and future stock option and performance share plans for group management. Between 2 and 6 February 2026, the company repurchased 60,263 ordinary shares on the EXM market at a volume-weighted average price of €47.4938.

Following these transactions, Recordati now holds 5,122,615 treasury shares, representing 2.450% of its share capital. The buyback reinforces the company’s capacity to implement equity-based incentive schemes, aligning management interests with shareholders and supporting its long-term remuneration and retention strategy.

The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on Borsa Italiana, offering therapeutic options in both general and specialist medicine as well as in rare diseases. The company operates in an integrated manner from clinical development through production, marketing and licensing of APIs and finished products, and is present in about 150 countries across EMEA, the Americas and APAC with more than 4,580 employees.

Average Trading Volume: 314,674

Technical Sentiment Signal: Hold

Current Market Cap: €9.74B

See more data about REC stock on TipRanks’ Stock Analysis page.